Skip to main content
. 2022 Oct 20;12:1002168. doi: 10.3389/fonc.2022.1002168

Table 3.

Vaccine-related reactions over the week after the third (booster) dose.

Not at all N (%) Mild N (%) Moderate N (%) Severe N (%) Overwhelming N (%) Mild to Overwhelming N (%) Severe to Overwhelming N (%)
Pain at the injection site 129 (40.3) 119 (37.2) 49 (15.3) 19 (5.9) 4 (1.3) 191 (59.7) 23 (7.2)
Fatigue 207 (64.7) 64 (20.0) 34 (10.6) 12 (3.8) 3 (0.9) 113 (35.3) 15 (4.7)
Headache 260 (81.3) 35 810.9) 18 (5.6) 6 (1.9) 1 (0.3) 60 (18.8) 7 (2.2)
Bone pain 226 (70.6) 53 (16.6) 23 (7.2) 15 (4.7) 3 (0.9) 94 (29.4) 18 (5.6)
Fever 267 (83.4) 30 (9.4) 5 (1.6) 16 (5.0) 2 (0.6) 53 (16.6) 18 (5.6)
Enlarged lymph nodes 311 (97.2) 4 (1.3) 4 (1.3) 1 (0.3) 9 (2.8) 1 (0.3)
Skin rash 315 (98.4) 3 (0.9) 1 (0.3) 1 (0.3) 5 (1.6) 1 (0.3)
Insomnia 296 (92.5) 17 (5.3) 4 (1.3) 2 (0.6) 1 (0.3) 24 (7.5) 3 (0.9)
Diarrhoea 305 (95.3) 9 (2.8) 5 (1.6) 1 (0.3) 15 (4.7) 1 (0.3)
Nausea or vomiting 304 (95.0) 9 (2.8) 5 (1.6) 2 (0.6) 16 (5.0) 2 (0.6)